CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82

Similar documents
Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN

NUCLEAR CARDIOLOGY UPDATE

Advantages of PET Myocardial Imaging

RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING

Myocardial Perfusion: Positron Emission Tomography

Preview of Presentation

PET for the Evaluation of Myocardial Viability

Positron emission tomography and molecular imaging

Photon Attenuation Correction in Misregistered Cardiac PET/CT

Pearls & Pitfalls in nuclear cardiology

Conflict of Interest Disclosure

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas

Rubidium-82 myocardial perfusion PET/CT

Myocardial blood flow PET evaluation and quantification. Dr. Erick Alexánderson. Rosas

Cardiac Imaging Tests

The Role of Nuclear Imaging in Heart Failure

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

Click here for Link to References: CMS Website HOPPS CY 2018 Final Rule. CMS Website HOPPS CY2018 Final Rule Updated November 2017.

I have no financial disclosures

Nuclear Cardiology Reimbursement. Todd Lamb, BS, AS, CNMT Clinical Operations Mgr Regions Hospital St. Paul, MN

A Snapshot on Nuclear Cardiac Imaging

SPECT or PET for Cardiovascular Screening in High-Risk Patients

Fellows on this rotation are expected to attend nuclear conferences and multimodality imaging conference.

海外研究留学報告 福島賢慈 東京女子医科大学 画像診断 核医学部 核医学地方会 2011 Jan

Positron emission tomography myocardial perfusion and glucose metabolism imaging

Update in Nuclear Cardiology: Patient-Centered Imaging Radiation Dose Reduction

Typical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?

Conflict of Interest Disclosure

Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging

Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation.

4D PET: promises and limitations

Journal of the American College of Cardiology Vol. 49, No. 10, by the American College of Cardiology Foundation ISSN /07/$32.

Nuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE.

Le FDG dans l évaluation de la viabilité : Quelle place par rapport aux autres traceurs?

SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin

Hybrid imaging of the heart

Current Tracers. João V. Vitola, MD, PhD. Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

PET myocard perfusion & viability Riemer Slart

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

CHRONIC CAD DIAGNOSIS

45 Hr PET Registry Review Course

2017 Qualified Clinical Data Registry (QCDR) Performance Measures

Cardiovascular Imaging

Cardiac PET. John Buscombe

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Medical Policy. MP Cardiac Applications of Positron Emission Tomography Scanning

The development of combined PET/CT scanners has

Diagnostic Performance of Positron Emission Tomography in the Detection of Coronary Artery Disease: A Meta-analysis 1

AMERICAN IMAGING MANAGEMENT

AMERICAN IMAGING MANAGEMENT

Tc-99m Sestamibi/Tetrofosmin Stress-Rest Myocardial Perfusion Scintigraphy

Pitfalls and Remedies in PET/CT imaging for RT planning

CARDIOLOGY IMAGING MODALITIES AND PATIENT EXPOSURE

Original Policy Date

POSITRON EMISSION TOMOGRAPHY (PET)

New Challenges in Nuclear Cardiology Practice

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος

05/02/ CPT Preauthorization Groupings Effective May 2, Computerized Tomography (CT) Abdomen 6. CPT Description SEGR CT01

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

BlueAdvantage SM. & BlueChoice SM Radiology Prior Authorization Program Code List CPT /HCPS

Identifying Image Artifacts, Their Causes and How to Fix Them: PET. Brad J Kemp, PhD Mayo Clinic, Rochester, MN

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

Evidence for myocardial CT perfusion imaging in the diagnosis of hemodynamically significant coronary artery disease

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

Cardiac Positron Emission Tomography

Value of Assessment of Viable and Ischemic Myocardium and Techniques Such as MRI, Radionuclide Imaging

Diagnostic Imaging Prior Review Code List 2 nd Quarter 2018

Diagnostic Imaging Utilization Management and Consultation Management Programs Imaging Code Listing for Connecticut, Maine and New Hampshire

Myocardial Perfusion SPECT How to do it E. Moralidis

Anthem Blue Cross and Blue Shield Virginia Advanced Imaging Procedures Requiring Precertification Revised 02/13/2013

Technical Meeting on: Current Role of Nuclear Cardiology in the Management of Cardiac Diseases Vienna, May 2008 Vienna International Centre

Zahid Rahman Khan, MD(USA), MS Diplomate American Board of Nuclear Medicine Consultant t Nuclear Medicine

Previous MI with no intervention

Stress only Perfusion Imaging

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors

Εξελίξεις και νέες προοπτικές στην καρδιαγγειακή απεικόνιση CT. Σταμάτης Κυρζόπουλος Ωνάσειο Καρδιοχειρουργικό Κέντρο

Radiologic Assessment of Myocardial Viability

Welcome! To submit questions during the presentation: or Text:

Prior Authorization for Non-emergency Cardiac Imaging Procedures

ASNC CONSENSUS STATEMENT REPORTING OF RADIONUCLIDE MYOCARDIAL PERFUSION IMAGING STUDIES. Approved August 2003

Research Article. Open Access. Mansour Al Moudi 1,2, Zhong-Hua Sun 2. 1 Introduction

NUCLEAR CARDIOLOGY AND ADVANCED VASCULAR IMAGING. Joel Kahn, MD, FACC

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis

Rotation: Imaging 2. Nuclear Cardiology (in Imaging 1 and 2)

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology

Stress Testing:Which Study is Indicated for My Patient?

Myocardial perfusion scintigraphy using rubidium-82 positron emission tomography

Clinical PET/CT imaging. PET/CT - Optimization of torso imaging. CT-based attenuation correction. PET/CT torso imaging

Radiology Codes Requiring Authorization*

Functional aspects of anatomical imaging techniques

State-of-the-Art SPECT/CT: Cardiac Imaging

Qualitative and Quantitative Assessment of Perfusion

The Integral Role of Metabolic and Perfusion Imaging in Assessment of Myocardial Scar: Comparison between 18F-FDG PET and 99Tc-Sestamibi

Nuclear Perfusion Imaging of Angina

Small-Cap Research. FluoroPharma Md (FPMI-OTCBB) FPMI: Industry Report : PET Growth 20% Through 2021 OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Patient-centered Imaging in Coronary Artery Disease. Jason H Cole, MD, MS, FACC January 10, 2015

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging. ID: GOLD Date: Age: 46 Sex: M John Doe Phone (310)

Transcription:

CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82 Pr Denis AGOSTINI Président du Groupe de Cardiologie Nucléaire et IRM CHU Caen Bordeaux 2006

Cardiac Perfusion-Metabolism Mismatch with PET Cumulative Survival 1.0 0.8 0.6 0.4 0.2 0 20 17 23 21 14 21 16 13 Revascularization Medical Therapy 16 14 10 14 13 8 13 13 8 13 10 0 4 8 12 16 20 24 28 32 Months of Follow-Up 7 Low Rank χ 2 =4.60 p=0.03 10 10 7 7

Objectives Background of cardiac PET Understand advantages of cardiac PET perfusion imaging Discuss cardiac PET and PET/CT imaging Quantification of coronary reserve : dream or reality?

Diagnostic Accuracy of PET Myocardial Perfusion Imaging for CAD Sensitivity (%) Specificity (%) No. Patients Agent Author 95 94 93 97 93 98 84 95 100 95 78 100 100 93 88 95 50 193 202 45 49 146 81 25 NH 3, 82 Rb 82 Rb 82 Rb NH 3 NH 3 82 Rb 82 Rb NH 3 Gould et al Demer et al Go et al Schelbert et al Yonekura et al Williams et al Stewart et al Tamaki et al 93 92 791 Average

Advantages of Cardiac PET Perfusion Imaging Improved efficiency 1 Lower radiation exposure 1 Fewer attenuation artifacts 1 Improved resolution 1 1. Bateman TM. PET Myocardial Perfusion Imaging: Making the Transition to a Clinical Routine. Appl Imaging: Applications Nucl Cardiol. 2002; 3(1): 1-6

Commercially Available Cardiac PET Agents in US Perfusion Imaging Rubidium Rb 82 N-13 Ammonia Viability Imaging F-18 Fluorodeoxyglucose (FDG)

Author Sensitivity & Specificity 2 Sensitivity Specificity Patients Gould 95% 100% 50 Demer 94% 95% 193 Go 93% 78% 202 Schelbert 97% 100% 45 Yonekura 93% 100% 49 Williams 98% 93% 146 Stewart 84% 88% 319 Weighted Avg. 93% +/- 8 92% +/- 5 766 2. Nuclear Medicine Self-Study Program III: Nuclear Medicine Cardiology. Botvinik, EH, Ed. 1998: SNM, Reston, VA.

Cardiac PET Tracers Agent Physical Half-life Mean Positron range (mm) Production Extraction 13 N NH 3 82 Rb 15 O H 2 O 18 F FDG 10.0 min 78 s 2.0 min 110 min 0.7 2.6 1.1 0.2 Cyclotron Generator Cyclotron Cyclotron 80 % 50-60 % Diffusible 1-3 %

CardioGen-82 (Rubidium Rb 82 Generator) Indication in US : Useful in distinguishing normal from abnormal myocardium in patients with suspected myocardial infarction.

CardioGen-82 (Rubidium Rb 82 Generator) Rubidium-82 (Rb-82) is produced by decay of Strontium-82 (Sr-82) 75 second T½ Kinetics: Potassium analog High extraction fraction at high flow rates Defects visualized 2-7 minutes after injection Same sized dose at stress & rest due to short T½ New generator every 28 days Dose available 24 hours per day, 7 days per week Pharmacologic stress studies ONLY

Cardiac Pet Tracer Dosimetry Agent Activity (mci) Critical Organ Organe Dose (rem) 13 N NH 3 82 Rb 15 O H 2 O 18 F FDG 20 60 60 10 Bladder Kidneys Heart Bladder 0.52 1.98 0.49 7.00 Less irradiation with Rb82 than technetium agents for technicians (MYOVIEW) (J Nucl Cardiol 2006)

Comparison of PET and SPECT Myocardial Perfusion Imaging for Detection of CAD in the Same Patients Author Tracer Accuracy (%) Sensitivity (%) Specificity (%) Go et al (n = 132) Stewart et al (n = 81) Tamaki et al (n = 51) Rb-82 Tl-201 Rb-82 Tl-201 NH3 Tl-201 92 78 85 78 98 98 95 79 87 87 98 96 82 76 82 52 100 100 Total PET SPECT 91 81 93 85 82 67

Sample Dedicated PET Protocol (35 min) Rb-82 Rb-82 Dipy 0.56 mg/kg Rb-82 Rest Tx Scan Emission Scan 2D 3D Gated Scan Stress Tx Scan Emission Scan 2D 3D Gated Scan 10 phases 30 seconds Approx 3 min 10 phases 30 seconds Approx 3 min Approx 4 min Approx 5 min Approx 5 min Approx 4 min Protocol courtesy of Timothy Bateman, MD Approximately 35 minutes

PET/CT Protocol (30 min) Rb-82 50-60 mci Dipy 0.56 mg/kg Rb-82 50-60 mci scout CT-trans 70-90 sec 90-120 sec gated rest pt out scoutct CT-trans 70-90 sec 90-120 sec gated stress Approx 1 min Approx 7 min Approx 6 min Approx 1 min Approx 7 min Protocol courtesy of Marcelo DiCarli,, MD Approximately 30 minutes

CASE 1 STRESS

Normal Database Comparison: PET vs. SPECT/ Rb-82 vs ammonia Stress Uncorrected Stress corrected Gender-matched Gender-combined SPECT PET Stress Gender-combined Ammonia Female Rb-82 Male 1-day rest/stress sestamibi protocol

The PET/CT design Gantry dimensions: 170 cm x 168 cm x 110 cm Rotation: 30 rpm 110 cm 60 cm CT PET 100 cm Dual-modality imaging range QC Issues: Table sag, patient motion, organ motion (ave. vs. instant)

* Avoid Misalignment between Emission & Transmission Sequential Scans Rest Stress Cardiac motion artifact: Heart moved during pharmacological stress John Votaw, Ph.D., 2003

PET/CT 1. CT used for attenuation correction (obeses patients) - CT vs. Radioactive sources 2. CT used for fusion of coronary anatomy and calcium deposits with perfusion distribution (risk stratification for CAD patients).

Calcium Deposit (Calcium scoring using CT) Soft Plaque (CT Coronary Angiography) LV Function Perfusion deficit (Perfusion stress and rest) PET/CT One-Stop Shop: Four Tests in One Sitting

DicPt1

Clinical Applications of Coronary Flow Reserve Quantification 1 - Verification of efficacy of pharmacological vasodilation 2 - Detection of global/diffuse disease 3 - Evaluation of extent of multivessel disease 4 - Evaluation of significance of individual vessel lesions 5 - Detection of coronary steal syndromecollaterals 6 - Evaluation of endothelial function 7 - Monitoring therapy

Conclusions Rb-82 is currently the best PET myocardial perfusion tracer available for clinical work. Rb-82 provides the most homogeneous normal distribution of myocardial perfusion. PET AC works better than SPECT and can be performed using either CT, Emission and transmission misregistrations due to patient motion or breathing can cause artifacts. QC should be routinely performed. Image fusion of CT angiography and PET perfusion is a promising clinical tool.

Prospective in France 1 st site in Europe (UK 2006) from US Cyclotron (Arronax) in Nantes 2009 to produce Rb82 generators in France and Europe The best parc of PET-CT in the world (today : 55 and 100 in the next 5 years) Compromise between oncology and cardiology in the nuclear department Selection of patients : obesity women and triple vessels disease

THE END (thanks to Bertrand Merino for your invitation in the Wine s Country)

REUNIONS DE LA SOCIETE FRANCAISE DE CARDIOLOGIE MARS-OCTOBRE OCTOBRE-DECEMBRE Prochaine réunion SFC: le 15 DECEMBRE 18h 20h MERIDIEN ETOILE PARIS -